SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-18-014365
Filing Date
2018-12-28
Accepted
2018-12-28 16:35:52
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGSTRATION STATEMENT endra_s3.htm S-3 335775
2 FORM OF INDENTURE RELATING TO THE ISSUANCE FROM TIME TO TIME IN ONE OR MORE SERI endra_ex48.htm EX-4.8 539701
3 OPINION OF K&L GATES LLP AS TO LEGALITY OF SECURITIES BEING REGISTERED endra_ex51.htm EX-5.1 35334
4 CONSENT OF RBSM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM endra_ex231.htm EX-23.1 4084
5 IMAGE endra_s3000.jpg GRAPHIC 8669
6 IMAGE endra_s3001.jpg GRAPHIC 11723
  Complete submission text file 0001654954-18-014365.txt   944347
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-229090 | Film No.: 181257754
SIC: 3845 Electromedical & Electrotherapeutic Apparatus